1 marketing is getting a lifestyle makeover. Novo Nordisk and Eli Lilly are increasingly pitching their blockbuster obesity drugs less around treating a chronic disease and more around weight loss and how consumers want to look and feel. (STAT News)
The Make America Health Again split shows all is not well with Health and Human Services Secretary Robert F. Kennedy Jr.’s health revolution. Divisions within the MAHA movement risk damaging Republicans just as MAHA prepares to test its political power for the first time at the midterm elections. (Financial Times)
AI could help create the next pandemic, and one startup wants AI to stop it.Red Queen Bio is using artificial intelligence to design antibody drugs against novel pathogens before more powerful AI systems could potentially be used to design dangerous biological threats. (The Wall Street Journal)
Meanwhile, Roche outlined plans to move towards autonomous AI labs.Roche is committed to “AI independence” in R&D and has recently started building autonomous AI-driven labs. (Reuters)
Sham scientific societies are misleading star researchers. An investigation reveals a network of organizations that have been building their ranks through deceptive practices. (Nature)
To read yesterday’s edition of Five things for pharma marketers to know, click here.
